Overview
Founder of Pamplona Bio in 2022/4, previously a researcher and doctoral supervisor at the Chinese Academy of Sciences’ Guangzhou Institutes of Biomedicine and Health, with core R&D roles at international drug companies including Amgen. The company’s proprietary ASTRIDE AI drug design platform focuses on targeted protein degradation.
Connected profiles
Explore
Sources · 0Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
潘普洛纳生物2022年4月创办者，历任中国科学院广州生物医药与健康研究院研究员、博士生导师，曾在安进（Amgen）等国际药企任核心研发职务；公司自研ASTRIDE AI药物设计平台，聚焦靶向蛋白降解。